Enabling rapid vaccine development through manufacturing innovation & process efficiency

Vaccine Insights 2023; 2(5), 147—159

DOI: 10.18609/vac.2023.025

Published: 21 June 2023
Expert Roundtable
Cleo Kontoravdi, Murali Muralidhara, Sirat Sikka, Hao Chen

Charlotte Barker, Editor, Vaccine Insights, speaks to (pictured left to right) Cleo Kontoravdi, Professor of Biological Systems Engineering, Imperial College London, Murali Muralidhara, Chief Manufacturing Officer RVAC Medicines, Sirat Sikka, Field Applications Scientist, Nucleic Acid Therapeutics, Thermo Fisher Scientific & Hao Chen, AVP, Vaccines Process R&D, Merck

The global effort to fight COVID saw the fastest vaccine rollout of all time, saving millions of lives. With the ongoing demand for COVID vaccines and the threat of future pandemics, maintaining and building global vaccine manufacturing capacity has never been more important. In this article, a panel of vaccine manufacturing experts discusses how they are meeting the need for rapid, flexible, and affordable vaccine production—and what we can learn from the accelerated development and manufacture of SARS-CoV-2 vaccines.